Search Results - "Wolberg, A. S."

Refine Results
  1. 1

    Plasma and cellular contributions to fibrin network formation, structure and stability by WOLBERG, A. S.

    “…Growing evidence suggests that fibrin network structure and stability are important determinants of haemostasis and thrombosis, with alterations in fibrin…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system by Allen, G. A., Wolberg, A. S., Oliver, J. A., Hoffman, M., Roberts, H. R., Monroe, D. M.

    Published in Journal of thrombosis and haemostasis (01-03-2004)
    “…Using a cell‐based model system of coagulation, we performed a systematic examination of the effect of varying individual procoagulant proteins (over the range…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Fibrinogen, red blood cells, and factor XIII in venous thrombosis by Walton, B. L., Byrnes, J. R., Wolberg, A. S.

    Published in Journal of thrombosis and haemostasis (01-06-2015)
    “…Summary Cardiovascular disease is the leading cause of death and disability worldwide. Among cardiovascular causes of death, venous thrombosis (VT) is ranked…”
    Get full text
    Journal Article
  6. 6

    Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency by Zucker, M., Seligsohn, U., Salomon, O., Wolberg, A. S.

    Published in Journal of thrombosis and haemostasis (01-07-2014)
    “…Summary Background Factor XI (FXI) deficiency is a rare autosomal recessive disorder. Many patients with even very low FXI levels (< 20 IU dL−1) are…”
    Get full text
    Journal Article
  7. 7

    Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia by Sauls, D. L., Wolberg, A. S., Hoffman, M.

    Published in Journal of thrombosis and haemostasis (01-02-2003)
    “…Elevated plasma homocysteine is associated with an increased risk of atherosclerosis and thrombosis. However, the mechanisms by which homocysteine might cause…”
    Get full text
    Journal Article
  8. 8

    Tissue factor–positive tumor microvesicles activate platelets and enhance thrombosis in mice by Geddings, J. E., Hisada, Y., Boulaftali, Y., Getz, T. M., Whelihan, M., Fuentes, R., Dee, R., Cooley, B. C., Key, N. S., Wolberg, A. S., Bergmeier, W., Mackman, N.

    Published in Journal of thrombosis and haemostasis (01-01-2016)
    “…Essentials Cancer patients have a high rate of venous thrombosis (VT) but the underlying mechanisms are unknown. Tumor‐derived, tissue factor‐positive…”
    Get full text
    Journal Article
  9. 9

    Differential contributions of monocyte‐ and platelet‐derived microparticles towards thrombin generation and fibrin formation and stability by ALEMAN, M. M., GARDINER, C., HARRISON, P., WOLBERG, A. S.

    Published in Journal of thrombosis and haemostasis (01-11-2011)
    “…Background: Microparticles (MPs) are sub‐micron vesicles shed by activated or apoptotic cells, including platelets and monocytes. Increased circulating MPs are…”
    Get full text
    Journal Article
  10. 10

    Analyzing fibrin clot structure using a microplate reader by Wolberg, A S, Gabriel, D A, Hoffman, M

    Published in Blood coagulation & fibrinolysis (01-09-2002)
    “…Fibrin clot structure studies are often performed using optical methods. For example, the clot's fiber structure can be assessed by measuring light scattering…”
    Get full text
    Journal Article
  11. 11

    Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α‐chain crosslinking by Beckman, J. D., Holle, L. A., Wolberg, A. S.

    Published in Journal of thrombosis and haemostasis (01-01-2018)
    “…Essentials Factor XIII (FXIII)‐mediated fibrin crosslinking is delayed in hemophilia. We determined effects of FXIII cotreatment with hemostatic agents on clot…”
    Get full text
    Journal Article
  12. 12

    Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms by Wolberg, A S, Monroe, D M, Roberts, H R, Hoffman, M R

    Published in Blood coagulation & fibrinolysis (01-06-1999)
    “…Coagulation is initiated on tissue-factor-bearing cells when factor VIIa complexes with membrane-bound tissue factor and activates factors X and IX. Cellular…”
    Get more information
    Journal Article
  13. 13

    Air pollution upregulates endothelial cell procoagulant activity via ultrafine particle-induced oxidant signaling and tissue factor expression by Snow, S J, Cheng, W, Wolberg, A S, Carraway, M S

    Published in Toxicological sciences (01-07-2014)
    “…Air pollution exposure is associated with cardiovascular events triggered by clot formation. Endothelial activation and initiation of coagulation are…”
    Get full text
    Journal Article
  14. 14

    Recombinant porcine factor VIII for high‐risk surgery in paediatric congenital haemophilia A with high‐titre inhibitor by Croteau, S. E., Abajas, Y. L., Wolberg, A. S., Nielsen, B. I., Marx, G. R., Baird, C. W., Neufeld, E. J., Monahan, P. E.

    “…Introduction High‐titre factor VIII (FVIII) inhibitors complicate peri‐operative haemostasis. Recombinant porcine FVIII (r‐pFVIII) may provide an alternative…”
    Get full text
    Journal Article
  15. 15

    The fibrinogen γA/γ′ isoform does not promote acute arterial thrombosis in mice by Walton, B. L., Getz, T. M., Bergmeier, W., Lin, F.‐C., Uitte de Willige, S., Wolberg, A. S.

    Published in Journal of thrombosis and haemostasis (01-05-2014)
    “…Summary Background Elevated plasma fibrinogen is associated with arterial thrombosis in humans and promotes thrombosis in mice by increasing fibrin formation…”
    Get full text
    Journal Article
  16. 16

    Plasma clot properties in patients with a mild-to-moderate bleeding tendency of unknown cause by Gebhart, J., Laczkovics, C., Posch, F., Ay, C., Reitter-Pfoertner, S. E., Haslacher, H., Muszbek, L., Wolberg, A. S., Pabinger, I.

    Published in Annals of hematology (01-08-2015)
    “…In a large proportion of patients with mild bleeding disorders (MBDs) no diagnosis can be established by routine coagulation tests. We investigated whether…”
    Get full text
    Journal Article
  17. 17

    MONITORING FIBRINOLYSIS WITH GLOBAL ASSAYS TO DETECT HYPER AND HYPOFIBRINOLYSIS PHENOTYPES by SAL Montalvao, Y Sang, S Reitsma, L Arzenares, MC Fernandes, BM Martinelli, LQ Silva, EV Paula, JM Annichino-Bizzacchi, AS Wolberg

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Introduction: The fibrinolytic system is an important component of hemostasis that acts as a balance of blood coagulation to protect the vasculature from…”
    Get full text
    Journal Article
  18. 18

    Deencryption of Cellular Tissue Factor Is Independent of Its Cytoplasmic Domain by Wolberg, A.S., Kon, R.H., Monroe, D.M., Ezban, M., Roberts, H.R., Hoffman, M.

    “…Tissue factor (TF) is a transmembrane molecule that, when exposed to plasma, is the key initiator of coagulation. Cellular TF activity is normally “encrypted”,…”
    Get full text
    Journal Article
  19. 19

    Elevated tissue factor expression contributes to exacerbated diabetic nephropathy in mice lacking eNOS fed a high fat diet by LI, F., WANG, C.‐H., WANG, J.‐G., THAI, T., BOYSEN, G., XU, L., TURNER, A. L., WOLBERG, A. S., MACKMAN, N., MAEDA, N., TAKAHASHI, N.

    Published in Journal of thrombosis and haemostasis (01-10-2010)
    “…Background: Human eNOS (NOS3) polymorphisms that lower its expression are associated with advanced diabetic nephropathy (DN), and the lack of eNOS accelerates…”
    Get full text
    Journal Article
  20. 20

    Enhanced cell‐associated plasminogen activator pathway but not coagulation pathway activity contributes to motility in metastatic breast cancer cells by CARTER, J. C., CAMPBELL, R. A., GIBBONS, J. A., GRAMLING, M. W., WOLBERG, A. S., CHURCH, F. C.

    Published in Journal of thrombosis and haemostasis (01-06-2010)
    “…Background: Activation of tumor cell‐associated coagulation and plasminogen activator pathways occurs in malignant disease processes, including breast cancer,…”
    Get full text
    Journal Article